ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 24 filers reported holding ADMA BIOLOGICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $446,000,000 | +57.6% | 75,000 | +114.3% | 0.01% | +100.0% |
Q1 2016 | $283,000,000 | -4.1% | 35,000 | -3.8% | 0.01% | 0.0% |
Q4 2015 | $295,000,000 | -3.0% | 36,400 | 0.0% | 0.01% | -16.7% |
Q3 2015 | $304,000,000 | -9.8% | 36,400 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $337,000,000 | -16.2% | 36,400 | -11.2% | 0.01% | -33.3% |
Q1 2015 | $402,000,000 | – | 41,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |